ORBIMED ADVISORS LLC Q1 2019 Filing
Filed May 15, 2019
Portfolio Value
$6.5B
Holdings
119
Report Date
Q1 2019
Filing Type
13F-HR
All Holdings (119 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ASNDASCENDIS PHARMA A S | 3,970,673 | $467.3B | 7234.81% | |
| 2 | 1T7TRICIDA INC | 10,889,280 | $420.5B | 6510.26% | |
| 3 | —CLEMENTIA PHARMACEUTICALS IN | 10,425,225 | $272.1B | 4212.23% | |
| 4 | ALXNALEXION PHARMACEUTICALS INC | 1,957,200 | $264.6B | 4095.76% | |
| 5 | ALECALECTOR INC | 13,182,329 | $246.8B | 3820.19% | |
| 6 | BSXBOSTON SCIENTIFIC CORP | 5,790,400 | $222.2B | 3440.34% | |
| 7 | MRKMERCK & CO INC | 2,570,100 | $213.8B | 3309.05% | |
| 8 | VRTXVERTEX PHARMACEUTICALS INC | 955,300 | $175.7B | 2720.35% | |
| 9 | NBIXNEUROCRINE BIOSCIENCES INC | 1,833,200 | $161.5B | 2500.19% | |
| 10 | —WRIGHT MED GROUP N V | 4,437,799 | $139.6B | 2160.61% | Call |
| 11 | —MYLAN N V | 4,861,800 | $137.8B | 2132.96% | |
| 12 | EWEDWARDS LIFESCIENCES CORP | 715,000 | $136.8B | 2117.76% | |
| 13 | TMOTHERMO FISHER SCIENTIFIC INC | 447,300 | $122.4B | 1895.36% | |
| 14 | ISRGINTUITIVE SURGICAL INC | 210,300 | $120.0B | 1857.56% | |
| 15 | GHGUARDANT HEALTH INC | 1,534,464 | $117.7B | 1821.95% | |
| 16 | —SYNTHORX INC | 5,316,355 | $108.3B | 1676.45% | |
| 17 | SRPTSAREPTA THERAPEUTICS INC | 828,400 | $98.7B | 1528.50% | |
| 18 | ELVANTHEM INC | 325,200 | $93.3B | 1444.74% | |
| 19 | BHCBAUSCH HEALTH COS INC | 3,740,700 | $92.4B | 1430.33% | |
| 20 | —PRINCIPIA BIOPHARMA INC | 2,605,713 | $88.6B | 1371.49% | |
| 21 | REGNREGENERON PHARMACEUTICALS | 214,800 | $88.2B | 1365.40% | |
| 22 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 3,618,171 | $84.0B | 1300.03% | |
| 23 | INSPINSPIRE MED SYS INC | 1,471,000 | $83.5B | 1292.98% | |
| 24 | —IMMUNOMEDICS INC | 4,270,403 | $82.0B | 1269.93% | |
| 25 | EHTHEHEALTH INC | 1,181,214 | $73.6B | 1139.94% | |
| 26 | PBYIPUMA BIOTECHNOLOGY INC | 1,880,000 | $72.9B | 1128.92% | |
| 27 | —AUDENTES THERAPEUTICS INC | 1,815,000 | $70.8B | 1096.35% | |
| 28 | ILMNILLUMINA INC | 227,300 | $70.6B | 1093.24% | |
| 29 | CLVSEURCLOVIS ONCOLOGY INC | 2,832,300 | $70.3B | 1088.25% | |
| 30 | EX9EXELIXIS INC | 2,801,900 | $66.7B | 1032.32% | |
| 31 | AG8AGILENT TECHNOLOGIES INC | 798,700 | $64.2B | 993.85% | |
| 32 | TEVATEVA PHARMACEUTICAL INDS LTD | 4,079,000 | $64.0B | 990.12% | |
| 33 | —LOGICBIO THERAPEUTICS INC | 6,466,783 | $63.9B | 989.08% | |
| 34 | PTCTPTC THERAPEUTICS INC | 1,519,700 | $57.2B | 885.52% | |
| 35 | BMYBRISTOL MYERS SQUIBB CO | 1,195,000 | $57.0B | 882.59% | |
| 36 | HUMHUMANA INC | 210,300 | $55.9B | 865.98% | |
| 37 | IOVAIOVANCE BIOTHERAPEUTICS INC | 5,548,326 | $52.8B | 816.83% | |
| 38 | —AVEDRO INC | 4,240,128 | $52.0B | 805.39% | |
| 39 | —ENDO INTL PLC | 6,165,464 | $49.5B | 766.43% | |
| 40 | ABTABBOTT LABS | 615,400 | $49.2B | 761.57% | |
| 41 | —MYOKARDIA INC | 906,600 | $47.1B | 729.66% | |
| 42 | ARGXARGENX SE | 361,300 | $45.1B | 698.25% | |
| 43 | CRNXCRINETICS PHARMACEUTICALS IN | 1,914,282 | $43.6B | 674.47% | |
| 44 | MGTXMEIRAGTX HOLDINGS PLC | 2,460,251 | $42.4B | 656.22% | |
| 45 | ZLABZAI LAB LTD | 1,401,318 | $41.4B | 640.17% | |
| 46 | CICIGNA CORP NEW | 252,600 | $40.6B | 628.87% | |
| 47 | TNDMTANDEM DIABETES CARE INC | 631,300 | $40.1B | 620.59% | |
| 48 | ARVNARVINAS INC | 2,678,810 | $39.5B | 612.09% | |
| 49 | VRAYQVIEWRAY INC | 5,149,019 | $38.1B | 589.05% | |
| 50 | ONCBEIGENE LTD | 282,500 | $37.3B | 577.27% | |
| 51 | APLSAPELLIS PHARMACEUTICALS INC | 1,837,300 | $35.8B | 554.64% | Call |
| 52 | TAKTAKEDA PHARMACEUTICAL CO LTD | 1,750,000 | $35.6B | 551.85% | Call |
| 53 | —OBSEVA SA | 2,605,531 | $33.3B | 515.89% | |
| 54 | —RESTORBIO INC | 4,830,387 | $32.9B | 509.98% | |
| 55 | PRTAPROTHENA CORP PLC | 2,435,278 | $29.5B | 457.30% | |
| 56 | GNFTYGENFIT S A | 1,230,314 | $29.5B | 457.11% | |
| 57 | BMRNBIOMARIN PHARMACEUTICAL INC | 326,500 | $29.0B | 448.98% | Put |
| 58 | GILDGILEAD SCIENCES INC | 443,800 | $28.9B | 446.63% | |
| 59 | KALAKALA PHARMACEUTICALS INC | 3,447,840 | $28.5B | 441.41% | |
| 60 | XTNTXTANT MED HLDGS INC | 9,207,012 | $28.1B | 434.71% | |
| 61 | CELGCELGENE CORP | 295,000 | $27.8B | 430.82% | |
| 62 | PRQRPROQR THRAPEUTICS N V | 1,982,031 | $27.5B | 425.58% | |
| 63 | HRTXHERON THERAPEUTICS INC | 1,069,000 | $26.1B | 404.45% | |
| 64 | CDNACAREDX INC | 827,600 | $26.1B | 403.83% | |
| 65 | NVLSEURALPINE IMMUNE SCIENCES INC | 3,670,955 | $25.2B | 389.85% | |
| 66 | CBAYUSDCYMABAY THERAPEUTICS INC | 1,874,955 | $24.9B | 385.45% | |
| 67 | CRVSCORVUS PHARMACEUTICALS INC | 5,967,584 | $24.0B | 371.38% | |
| 68 | AMGNAMGEN INC | 122,100 | $23.2B | 359.10% | |
| 69 | —HARPOON THERAPEUTICS INC | 2,446,409 | $23.2B | 358.64% | |
| 70 | ENTAENANTA PHARMACEUTICALS INC | 233,100 | $22.3B | 344.69% | |
| 71 | NTRANATERA INC | 1,077,586 | $22.2B | 343.98% | |
| 72 | RYTMRHYTHM PHARMACEUTICALS INC | 787,300 | $21.6B | 334.07% | |
| 73 | BIIBBIOGEN INC | 87,700 | $20.7B | 320.93% | |
| 74 | AUPHAURINIA PHARMACEUTICALS INC | 3,149,810 | $20.5B | 316.95% | |
| 75 | ASMBASSEMBLY BIOSCIENCES INC | 996,123 | $19.6B | 303.64% | |
| 76 | —FOAMIX PHARMACEUTICALS LTD | 5,195,330 | $19.5B | 301.59% | |
| 77 | SIBNSI BONE INC | 985,368 | $18.6B | 287.38% | |
| 78 | SVASINOVAC BIOTECH LTD | 2,839,500 | $18.4B | 284.41% | |
| 79 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 2,165,524 | $17.4B | 269.86% | |
| 80 | NVONOVO-NORDISK A S | 330,000 | $17.3B | 267.23% | |
| 81 | AMRNAMARIN CORP PLC | 817,600 | $17.0B | 262.75% | Call |
| 82 | DC4DEXCOM INC | 138,700 | $16.5B | 255.72% | |
| 83 | VRCAVERRICA PHARMACEUTICALS INC | 1,479,733 | $16.0B | 247.63% | |
| 84 | —SYNLOGIC INC | 2,029,996 | $15.4B | 238.52% | |
| 85 | SPYSPDR S&P 500 ETF TR | 50,000 | $14.1B | 218.65% | Put |
| 86 | —NABRIVA THERAPEUTICS PLC | 4,644,600 | $11.3B | 175.44% | |
| 87 | —CONSTELLATION PHARMCETICLS I | 835,842 | $11.3B | 175.33% | |
| 88 | SYKSTRYKER CORP | 54,000 | $10.7B | 165.12% | |
| 89 | SCPHSCPHARMACEUTICALS INC | 3,409,865 | $10.2B | 158.37% | |
| 90 | —NOVUS THERAPEUTICS INC | 2,537,110 | $10.2B | 157.89% | |
| 91 | —MERSANA THERAPEUTICS INC | 1,891,119 | $9.9B | 153.99% | |
| 92 | VRNAVERONA PHARMA PLC | 1,250,396 | $8.1B | 125.83% | |
| 93 | AM6AMICUS THERAPEUTICS INC | 518,309 | $7.0B | 109.12% | |
| 94 | WVEWAVE LIFE SCIENCES LTD | 180,000 | $7.0B | 108.26% | Put |
| 95 | SELBUSDSELECTA BIOSCIENCES INC | 2,879,064 | $6.8B | 105.62% | |
| 96 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 1,243,200 | $6.5B | 100.84% | |
| 97 | SPROSPERO THERAPEUTICS INC | 507,471 | $6.5B | 100.64% | |
| 98 | XENEXENON PHARMACEUTICALS INC | 634,812 | $6.5B | 99.85% | |
| 99 | NTLAINTELLIA THERAPEUTICS INC | 377,600 | $6.4B | 99.83% | |
| 100 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 1,350,655 | $5.8B | 89.91% |
Page 1 of 2Next